celastrol has been researched along with Spinal Cord Injuries in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, S; Li, C; Li, J; Liu, Q; Pang, Y; Shen, W; Wang, X; Wang, Z; Xu, Z | 1 |
| Kaur, J; Mladinic, M; Nistri, A; Petrović, A; Tomljanović, I | 1 |
| Dai, W; Li, C; Teng, H; Wang, B; Wang, J; Wang, X | 1 |
| Fu, J; Li, Y; Lin, D; Qiu, Y; Ren, J; Yang, L; Zhu, C | 1 |
4 other study(ies) available for celastrol and Spinal Cord Injuries
| Article | Year |
|---|---|
The discovery of the new mechanism: Celastrol improves spinal cord injury by increasing cAMP through VIP-ADCYAP1R1-GNAS pathway.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Chromogranins; GTP-Binding Protein alpha Subunits, Gs; Pentacyclic Triterpenes; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Spinal Cord; Spinal Cord Injuries; Triterpenes | 2023 |
Pharmacological induction of Heat Shock Protein 70 by celastrol protects motoneurons from excitotoxicity in rat spinal cord in vitro.
Topics: Animals; Animals, Newborn; Cell Line, Tumor; Cell Survival; Female; HSP70 Heat-Shock Proteins; Humans; Kainic Acid; Locomotion; Male; Motor Neurons; Neuroprotective Agents; Pentacyclic Triterpenes; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Triterpenes | 2019 |
Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Female; Humans; Inflammation; Interleukin-18; Lipopolysaccharides; Microglia; Neuroprotective Agents; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Pyroptosis; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries; Triterpenes | 2019 |
Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 2.
Topics: Analgesics; Animals; Camphanes; Carrageenan; Disease Models, Animal; Edema; Hyperalgesia; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred C57BL; Neuralgia; Pentacyclic Triterpenes; Pyrazoles; Receptor, Cannabinoid, CB2; Signal Transduction; Spinal Cord Injuries; Tripterygium; Triterpenes; Tumor Necrosis Factor-alpha | 2014 |